Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $77.75 | $17.20 | 352.04% | 323.96x | 22.64x | 23.75x | 63.68x | 1.59x | $41.15M | 0.60% | $108.58M | 1.23 | $6.87B | 128.30 | ||
| CORT | CORCEPT THERAPEUTICS INC | $89.57 | $23.52 | 280.88% | 194.72x | 150.11x | 12.16x | 15.07x | 1.38x | $119.79M | 1.28% | $637.99M | 6.11 | $9.52B | -1,386.02 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $279.14 | $90.78 | 207.50% | 64.02x | 37.27x | 8.65x | 34.66x | 1.33x | $641.34M | 1.73% | $1.08B | 8.09 | $38.53B | 41.68 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.70 | $2.75 | 216.42% | 124.29x | 76.38x | 4.71x | 115.44x | 1.19x | $47.52M | 3.21% | $13.01M | 0.08 | $1.65B | 30.86 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $61.69 | $16.85 | 266.07% | 62.95x | 48.32x | 6.26x | 7.84x | 1.71x | $164.23M | 3.48% | $605.69M | 7.92 | $4.57B | 40.95 | ||
| KRYS | KRYSTAL BIOTECH INC | $350.24 | $92.79 | 277.45% | 45.19x | 44.74x | 24.58x | 8.09x | 2.16x | $237.38M | 2.31% | $1.28B | 43.59 | $9.83B | 45.96 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.95 | $39.26 | 50.15% | 42.11x | 15.95x | 3.50x | 1.83x | 0.60x | $767.06M | 6.76% | $6.21B | 32.27 | $9.75B | 20.21 | ||
| ADMA | ADMA BIOLOGICS INC | $8.68 | $8.95 | -3.04% | 12.58x | 10.35x | 4.02x | 5.15x | 0.52x | $107.90M | 5.26% | $390.33M | 1.65 | $2.07B | 9.35 | ||
| HALO | HALOZYME THERAPEUTICS INC | $75.82 | $69.39 | 9.26% | 25.61x | 9.13x | 5.94x | 40.95x | 0.46x | $667.65M | 7.45% | $219.64M | 1.86 | $10.83B | 17.35 | ||
| VCEL | VERICEL CORP | $46.72 | $8.89 | 425.61% | 108.65x | 96.91x | 8.12x | 6.70x | 2.28x | $47.49M | 2.00% | $356.23M | 7.02 | $2.37B | 58.67 | ||
| RPRX | ROYALTY PHARMA PLC | $56.31 | $38.80 | 45.12% | 29.48x | 10.56x | 10.08x | 3.26x | 0.63x | $2.34B | 9.52% | $9.94B | 22.75 | $40.80B | 35.07 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $239.32 | $47.82 | 400.48% | 509.19x | 9.25x | 3.34x | 3.31x | 1.72x | $1.30B | 8.76% | $4.53B | 73.22 | $18.57B | 27.51 | ||
| ASND | ASCENDIS PHARMA A | $268.57 | $78.67 | 241.38% | 28.47x | 18.29x | 16.38x | 29.06x | 2.90x | $52.94M | 0.32% | $574.09M | 9.24 | $17.06B | 182.96 | ||
| TGTX | TG THERAPEUTICS INC | $56.41 | $20.27 | 178.26% | 17.52x | 40.59x | 11.63x | 14.81x | 4.90x | -$14.19M | -0.17% | $583.13M | 4.04 | $8.94B | 59.62 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.90 | $34.84 | 0.16% | 13.79x | 9.56x | 2.24x | 2.22x | 0.52x | $341.79M | 16.94% | $910.35M | 15.75 | $1.59B | 6.71 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $296.26 | $91.82 | 222.66% | 37.50x | 32.64x | 21.46x | 5.95x | 1.89x | $122.22M | 2.07% | $997.32M | 50.16 | $6.27B | 27.82 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.70 | $8.74 | -80.54% | 6.30x | -5.75x | 1.59x | 1.86x | 0.08x | $7.24M | 7.41% | $52.93M | 0.92 | $44.78M | 2.89 | ||
| TECH | BIO-TECHNE CORP | $71.48 | $16.30 | 338.64% | 100.68x | 34.26x | 9.23x | 5.37x | 1.85x | $269.60M | 2.41% | $2.09B | 13.34 | $11.27B | 44.04 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.49 | $12.44 | 153.13% | 17.40x | 15.81x | 6.45x | 3.81x | 3.26x | $208.13M | 5.40% | $1.01B | 8.28 | $3.10B | 9.26 | ||
| UTHR | UNITED THERAPEUTICS CORP | $531.79 | $235.22 | 126.08% | 18.16x | 19.15x | 7.30x | 3.83x | 2.04x | $1.02B | 4.40% | $5.90B | 135.66 | $21.29B | 12.43 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $477.08 | $163.38 | 192.01% | 28.05x | 24.41x | 9.92x | 6.25x | 2.05x | $3.71B | 3.06% | $19.36B | 76.20 | $117.58B | 21.80 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.47 | $2.39 | 45.02% | 14.46x | 14.67x | 2.13x | 3.36x | 0.98x | $4.11M | 1.47% | $82.33M | 1.03 | $212.39M | 10.00 | ||
| EXEL | EXELIXIS INC | $55.55 | $30.25 | 83.64% | 17.80x | 17.07x | 6.04x | 7.21x | 1.27x | $917.69M | 6.39% | $1.94B | 7.49 | $13.91B | 13.17 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $664.45 | $424.01 | 56.71% | 15.61x | 14.11x | 4.63x | 2.22x | 1.06x | $4.11B | 5.95% | $31.42B | 302.15 | $69.40B | 12.08 | ||
| VCYT | VERACYTE INC | $59.51 | $7.41 | 703.26% | 53.61x | 53.67x | 8.74x | 3.53x | 11.32x | $155.34M | 3.28% | $1.34B | 16.90 | $4.52B | 39.31 | ||
| INCY | INCYTE CORP | $115.09 | $63.16 | 82.22% | 15.79x | 14.54x | 4.28x | 4.09x | 1.46x | $1.45B | 6.32% | $5.62B | 28.21 | $19.56B | 10.46 | ||
| MDXG | MIMEDX GROUP INC | $4.27 | $1.21 | 253.81% | 20.33x | -50.71x | 1.63x | 2.62x | 10.71x | $69.36M | 10.94% | $242.94M | 1.64 | $493.82M | 9.07 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.61 | $3.16 | 456.62% | 29.35x | 4.81x | 0.85x | 1.24x | 65.39x | $109.24M | 5.91% | $1.51B | 14.34 | $2.43B | 29.39 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.